Skip to content
Global Vision Media

The Zimbabwean Government Rejects ‘One-Sided’ American Healthcare Assistance Package Because of Information Concerns

Medical aid illustration
The offered American financial assistance was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has rejected a substantial American health deal worth 367 million US dollars (£272m) spanning five years because of the United States' request for sensitive data.

This move became public following a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa felt the agreement was "unbalanced".

A government spokesperson has since clarified that the United States was demanding access to genetic material for research and commercial purposes while refused to share the benefits from any future treatments.

"We are forced to start the challenging and unfortunate process of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had furnished more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has urged more talks to secure a deal suitable to both sides so the nation's critical HIV programme can proceed.

Broader Background

This rejection comes after a similar situation in neighbouring Kenya, where a high court halted a related deal with the US following concerns were filed about the security of citizens' health data.

Since resuming office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

The agency had administered assistance for the US government, but Trump claimed its spending was "inefficient" and his government was seeking government-to-government agreements to enhance openness and responsibility.

As per statements, Sixteen nations in Africa have to date signed these new health pacts, constituting more than $18.3bn of fresh investment.

Details of the Declined Deal

The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this collaboration might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported programmes," the Ambassador commented.

However, government spokesperson Nick Mangwana said the arrangement was "unfair".

"Our nation was requested to provide its genetic material and health information for a long time, without any corresponding assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.

"Put simply, our nation would supply the raw materials for scientific discovery with no certainty that the end products would be accessible to our citizens if a new pandemic arise."

National Interest and International Frameworks

Mangwana further noted that the American exit from the global health body and its push of one-on-one health agreements were disrupting structures already set up through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.

"This framework is designed to guarantee that when a country contributes its samples, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."

These objections regarding the US deal "must not be interpreted as hostility towards the US," he added.

"We are open to continued dialogue with our American counterparts on how subsequent collaboration might be designed in a way that respects the sovereignty and dignity of both nations."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that negotiations should continue considering much of the nation's Aids initiatives depended on international support.

"In cases where technical issues arise, including those relating to data governance or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," the group commented.

The halted deal underscores the ongoing challenges between receiving crucial foreign assistance and safeguarding local interests in an increasingly data-driven world.

About the author

Jamie Barnes

Elara Voss is a journalist and storyteller exploring global cultures and human experiences.

Global Vision Media

Type to search articles.